Florida’s insurance commissioner has fined 13 pharmacy benefit managers a combined $12.66 million for violating state law, including insurer-owned PBM units.
The penalties stem from market conduct examinations under Florida’s Prescription Drug Reform Act, which took effect in 2023. Regulators found violations related to fair pricing, network adequacy, pharmacy remittances and unilateral changes to pharmacy contracts, according to a Nov. 9 news release.
Several of the penalized PBMs are contesting the findings in court, according to Florida’s Office of Insurance Regulation. The agency said some organizations have also refused to cooperate with ongoing examinations, and that in some cases examiner invoices have gone unpaid since January 2025.
The full list of penalties:
- Employee Health Insurance Mgmt.: $2.415 million
- Scrip World (CVS Health): $2.23 million
- Right Rx FL: $2.115 million
- ProAct: $1.845 million
- Capital Rx (now Judi Health): $1.59 million
- Slate Rx: $1.36 million
- Drexi: $355,000
- PerformRx (AmeriHealth Caritas): $335,000
- MC-21 Healthcare: $310,000
- Benecard Services: $60,000
- CarelonRx (Elevance Health): $20,000
- Prime Therapeutics Management (19 BCBS plans): $20,000
- Prime Therapeutics (19 BCBS plans): $5,000
